Advertisement
Published in:
2018 | OriginalPaper | Chapter
Screvo: 3D Screening Devices for In Vitro and In Vivo Applications
Author : Julian Higuera
Published in: Supporting University Ventures in Nanotechnology, Biomaterials and Magnetic Sensing Applications
Publisher: Springer International Publishing
Activate our intelligent search to find suitable subject content or patents.
Select sections of text to find matching patents with Artificial Intelligence. powered by
Select sections of text to find additional relevant content using AI-assisted search. powered by
Abstract
Screvo BV is an early-stage biotech company founded in 2012 whose mission is to optimize the number of experimental animals in preclinical research. It is a spin-off from the Tissue Regeneration department of the MIRA Institute for Biomedical Technology of the University Twente, The Netherlands. Screvo’s first product, Vers3D, is an implantable well system that can be used in a wide variety of in vitro and in vivo applications. By increasing the number of conditions simultaneously screened in one animal, animal testing of drugs and treatments is at least three times more time-efficient and at least nine times more cost-effective thanks to this exciting new product.